tetano
Editor, Senior Moderator
PLoS One
. 2024 Feb 16;19(2):e0297291.
doi: 10.1371/journal.pone.0297291. eCollection 2024. Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro
Marina Rius-Salvador[SUP] 1 [/SUP], Maria Jesús García-Múrria[SUP] 1 [/SUP], Luciana Rusu[SUP] 2 [/SUP], Manuel Bañó-Polo[SUP] 3 [/SUP], Rubén León[SUP] 3 [/SUP], Ron Geller[SUP] 2 [/SUP], Ismael Mingarro[SUP] 1 [/SUP], Luis Martinez-Gil[SUP] 1 [/SUP]
Affiliations
Background: The oral cavity is the site of entry and replication for many respiratory viruses. Furthermore, it is the source of droplets and aerosols that facilitate viral transmission. It is thought that appropriate oral hygiene that alters viral infectivity might reduce the spread of respiratory viruses and contribute to infection control.
Materials and methods: Here, we analyzed the antiviral activity of cetylpyridinium chloride (CPC), chlorhexidine (CHX), and three commercial CPC and CHX-containing mouthwash preparations against the Influenza A virus and the Respiratory syncytial virus. To do so the aforementioned compounds and preparations were incubated with the Influenza A virus or with the Respiratory syncytial virus. Next, we analyzed the viability of the treated viral particles.
Results: Our results indicate that CPC and CHX decrease the infectivity of both the Influenza A virus and the Respiratory Syncytial virus in vitro between 90 and 99.9% depending on the concentration. Likewise, CPC and CHX-containing mouthwash preparations were up to 99.99% effective in decreasing the viral viability of both the Influenza A virus and the Respiratory syncytial virus in vitro.
Conclusion: The use of a mouthwash containing CPC or CHX alone or in combination might represent a cost-effective measure to limit infection and spread of enveloped respiratory viruses infecting the oral cavity, aiding in reducing viral transmission. Our findings may stimulate future clinical studies to evaluate the effects of CPC and CHX in reducing viral respiratory transmissions.
. 2024 Feb 16;19(2):e0297291.
doi: 10.1371/journal.pone.0297291. eCollection 2024. Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro
Marina Rius-Salvador[SUP] 1 [/SUP], Maria Jesús García-Múrria[SUP] 1 [/SUP], Luciana Rusu[SUP] 2 [/SUP], Manuel Bañó-Polo[SUP] 3 [/SUP], Rubén León[SUP] 3 [/SUP], Ron Geller[SUP] 2 [/SUP], Ismael Mingarro[SUP] 1 [/SUP], Luis Martinez-Gil[SUP] 1 [/SUP]
Affiliations
- PMID: 38363760
- DOI: 10.1371/journal.pone.0297291
Background: The oral cavity is the site of entry and replication for many respiratory viruses. Furthermore, it is the source of droplets and aerosols that facilitate viral transmission. It is thought that appropriate oral hygiene that alters viral infectivity might reduce the spread of respiratory viruses and contribute to infection control.
Materials and methods: Here, we analyzed the antiviral activity of cetylpyridinium chloride (CPC), chlorhexidine (CHX), and three commercial CPC and CHX-containing mouthwash preparations against the Influenza A virus and the Respiratory syncytial virus. To do so the aforementioned compounds and preparations were incubated with the Influenza A virus or with the Respiratory syncytial virus. Next, we analyzed the viability of the treated viral particles.
Results: Our results indicate that CPC and CHX decrease the infectivity of both the Influenza A virus and the Respiratory Syncytial virus in vitro between 90 and 99.9% depending on the concentration. Likewise, CPC and CHX-containing mouthwash preparations were up to 99.99% effective in decreasing the viral viability of both the Influenza A virus and the Respiratory syncytial virus in vitro.
Conclusion: The use of a mouthwash containing CPC or CHX alone or in combination might represent a cost-effective measure to limit infection and spread of enveloped respiratory viruses infecting the oral cavity, aiding in reducing viral transmission. Our findings may stimulate future clinical studies to evaluate the effects of CPC and CHX in reducing viral respiratory transmissions.